CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIENCY (USD $) In Thousands, except Share data, unless otherwise specified	12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011
Increase (Decrease) in Stockholders' Deficiency
Balance	$ (26,253)	$ (25,180)
Balance (in shares)	18,582,954
Share-based compensation expense	489	646
Issuance of shares for incentive plan	150
Shares cancelled to pay tax liability	(137)	(122)
Other comprehensive loss-pension (Note 8)	(4,010)	(6,675)
Net income (loss)	(4,602)	5,078
Balance	(34,363)	(26,253)
Balance (in shares)	18,664,068	18,582,954
Common Stock
Increase (Decrease) in Stockholders' Deficiency
Balance	75,933	75,461
Balance (in shares)	18,583,000	18,516,000
Issuance of shares for incentive plan	150
Issuance of shares for incentive plan (in shares)	39,000
Vested restricted stock issued	464	594
Vested restricted stock issued (in shares)	79,000	92,000
Shares cancelled to pay tax liability	(137)	(122)
Shares cancelled to pay tax liability (in shares)	(37,000)	(25,000)
Balance	76,410	75,933
Balance (in shares)	18,664,000	18,583,000
Additional Paid in Capital
Increase (Decrease) in Stockholders' Deficiency
Balance	9,211	9,159
Share-based compensation expense	489	646
Vested restricted stock issued	(464)	(594)
Balance	9,236	9,211
Accumulated Deficit
Increase (Decrease) in Stockholders' Deficiency
Balance	(87,828)	(92,906)
Net income (loss)	(4,602)	5,078
Balance	(92,430)	(87,828)
Accumulated Other Comprehensive Loss
Increase (Decrease) in Stockholders' Deficiency
Balance	(23,569)	(16,894)
Other comprehensive loss-pension (Note 8)	(4,010)	(6,675)
Balance	$ (27,579)	$ (23,569)